Cancer Research Horizons (CRH) is on the lookout for potentially transformative oncology drugs that could benefit from its expertise. CRH, which is the innovation arm of the charity Cancer Research UK ...

There has been much discussion recently about how artificial intelligence and machine learning (AI/ML) will revolutionize pharmaceutical research. Substantial progress has been made in the discovery ...

Developing high-quality, safe, and effective drugs is a complex process that requires varied scientific skills and stringent regulatory assessments. Drug development is a process that spans many years ...

BOSTON, Oct. 24, 2023 /PRNewswire/ -- PhaseV a pioneer in causal machine learning (ML) technology that optimizes clinical trial design and analysis, announced today that it has raised $15 million in ...

When it comes to developing new drugs, one of the most time-consuming and complex pieces of the puzzle is the task of compiling all of the data collected throughout the clinical development process to ...

Designation Facilitates and Expedites Development of Drugs for Patients with Serious Unmet Medical Needs Enrollment Progressing in NVG-291 Phase 1b/2a Clinical Trial, with Initial Cohort Data Expected ...

RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--Simulations Plus, Inc. (Nasdaq: SLP) (“Simulations Plus”), a leading provider of cheminformatics, biosimulation, simulation-enabled performance and ...

Pluri, Inc. ('Pluri”, the 'Company”, 'we” or 'us”) (Nasdaq, TASE: PLUR), a leading biotechnology company leveraging its ...

Syneos Health SYNH recently announced a strategic collaboration that will expand its relationship with Oracle. The partnership will utilize the Oracle Cerner Learning Health Network (“LHN”) and the ...

RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--Novella Clinical, a full service clinical research organization (CRO), today announced two new hires to supplement business development efforts on the ...